New-generation Myval transcatheter heart valve in severe aortic stenosis
- PMID: 38795718
- DOI: 10.1016/S0140-6736(24)00935-8
New-generation Myval transcatheter heart valve in severe aortic stenosis
Conflict of interest statement
We declare no competing interests.
Comment on
- 
  
  Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.N Engl J Med. 2019 May 2;380(18):1706-1715. doi: 10.1056/NEJMoa1816885. Epub 2019 Mar 16. N Engl J Med. 2019. PMID: 30883053 Clinical Trial.
- 
  
  Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16. N Engl J Med. 2019. PMID: 30883058 Clinical Trial.
- 
  
  LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.Lancet. 2024 Jun 22;403(10445):2695-2708. doi: 10.1016/S0140-6736(24)00821-3. Epub 2024 May 22. Lancet. 2024. PMID: 38795719 Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
 
        